[18F]-FDG PET/MRI in Locally Advanced Rectal Cancer (LARC) after Preoperative Chemo-Radiotherapy (pCRT): a comparison with conventional imaging

被引：0
|
作者：
Zucchetta, P. [1 ]
Crimi, F. [1 ]
Lacognata, C. [1 ]
Pucciarelli, S. [1 ]
Bodanza, V. [1 ]
Pomerri, F. [1 ]
Cecchin, D. [1 ]
Bui, F. [1 ]
机构：
[1] Univ Hosp Padova, Padua, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2018年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-303
引用
收藏
页码：S99 / S100
页数：2
相关论文
共 50 条
  • [21] What value does the 18F-FDG-Signal have in functional imaging after definitive chemo-radiotherapy of locally advanced lung cancers?
    Pottgen, C.
    Berkovic, K.
    Gauler, T.
    Krbek, T.
    Welter, S.
    Gohlert, A.
    Grehl, S.
    Teschler, H.
    Stamatis, G.
    Bockisch, A.
    Eberhardt, W.
    Stuschke, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2007, 183 : 41 - 42
  • [22] Impact of gut microbiota and immune contexture on effectiveness of neo-adjuvant chemo-radiotherapy in locally advanced rectal cancer (LARC)
    Roesel, R.
    Basso, C.
    Epistolio, S.
    Djordjevic, J.
    Sorrenti, E.
    Terzaghi, L.
    Galafassi, J.
    Spina, P.
    Popeskou, S. G.
    Mongelli, F.
    Frattini, M.
    Iezzi, G.
    Christoforidis, D.
    BRITISH JOURNAL OF SURGERY, 2022, 109 (SUPPL 3)
  • [23] DIFFUSION WEIGHTED MAGNETIC RESONANCE, FDG-PET AND 18F FAZA PET IMAGING IN PREDICTING RESPONSE TO NEOADJUVANT CHEMO-RADIOTHERAPY IN OESOPHAGEAL CARCINOMA
    Small, C.
    Joseph, K.
    McEwan, A.
    Wachowicz, K.
    Riauka, T.
    Bedard, E.
    Usmani, N.
    Roa, W.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S44 - S44
  • [24] [18F]FDG-PET/CT metabolic parameters as useful prognostic factors in cervical cancer patients treated with chemo-radiotherapy
    Herrera, Fernanda G.
    Breuneval, Thomas
    Prior, John O.
    Bourhis, Jean
    Ozsahin, Mahmut
    RADIATION ONCOLOGY, 2016, 11
  • [25] [18F]FDG-PET/CT metabolic parameters as useful prognostic factors in cervical cancer patients treated with chemo-radiotherapy
    Fernanda G. Herrera
    Thomas Breuneval
    John O. Prior
    Jean Bourhis
    Mahmut Ozsahin
    Radiation Oncology, 11
  • [26] Patterns of failure for esophageal cancer patients optimally staged with 18-F-FDG-PET and observed after chemo-radiotherapy
    Monjazeb, A. N.
    Farmer, M. R.
    Mattern, M.
    Mebea, A.
    Levine, E. A.
    Geisinger, K. R.
    Mishra, G.
    Melin, S.
    Blackstock, A. W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S274 - S274
  • [27] RECURRENCE ANALYSIS IN 133 CONSECUTIVE PATIENTS TREATED WITH NEOADJUVANT CHEMO-RADIOTHERAPY FOLLOWED BY TME SURGERY FOR LOCALLY ADVANCED RECTAL CANCER (LARC)
    Di Tullio, Piergiorgio
    Pinto, Carmine
    Di Fabio, Francesca
    Pini, Sara
    Cuicchi, Dajana
    Iacopino, Bruno
    Ceccarelli, Claudio
    Lombardi, Raffaele
    Neri, Stefano
    Ugolini, GianPaolo
    Tardio, Maria Lucia
    Cola, Bruno
    Martoni, Andrea Angelo
    ANNALS OF ONCOLOGY, 2009, 20
  • [28] Predictive value of baseline 18F-FDG-PET in seventy patients with rectal cancer treated with neoadjuvant chemo-radiotherapy (Bologna Project)
    Di Fabio, F.
    Pinto, C.
    Pini, S.
    Fanti, S.
    Cuicchi, D.
    Lacopino, B.
    Di Tullio, P.
    Lombardi, R.
    Castellucci, P.
    Neri, S.
    Cola, B.
    Martoni, A.
    ANNALS OF ONCOLOGY, 2008, 19 : 72 - 72
  • [29] Predictive value of baseline 18F-FDG-PET in fifty patients with rectal cancer treated with neoadjuvant chemo-radiotherapy (Bologna Project)
    Longobardi, Ciro
    Pinto, Carmine
    Di Fabio, Francesca
    Fanti, Stefano
    Cuicchi, Dajana
    Iacopino, Bruno
    Lombardi, Raffaele
    Castellucci, Paolo
    Neri, Stefano
    Cola, Bruno
    Martoni, Andrea Angelo
    ANNALS OF ONCOLOGY, 2007, 18 : 19 - 19
  • [30] Quality of life assessment through the EORTC questionnaires of locally advanced rectal cancer patients treated with preoperative chemo-radiotherapy
    Arraras Urdaniz J.I.
    Arias de la Vega F.
    Vera García R.
    Burgaleta A.M.
    Aguillo M.M.
    Iturre E.V.
    Pascual E.S.
    Clinical and Translational Oncology, 2006, 8 (6) : 423 - 429
12345